Compare AU & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AU | TFX |
|---|---|---|
| Founded | 1944 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.5B | 5.8B |
| IPO Year | 2023 | 1994 |
| Metric | AU | TFX |
|---|---|---|
| Price | $94.20 | $126.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | $116.88 | ★ $154.73 |
| AVG Volume (30 Days) | ★ 1.6M | 690.1K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.79% | 1.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.08 |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $25.63 | $13.83 |
| Revenue Next Year | $8.74 | $4.35 |
| P/E Ratio | ★ $23.93 | $60.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $62.55 | $100.18 |
| 52 Week High | $129.14 | $145.00 |
| Indicator | AU | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 38.65 | 42.16 |
| Support Level | $89.75 | $124.49 |
| Resistance Level | $98.06 | $127.49 |
| Average True Range (ATR) | 2.44 | 3.36 |
| MACD | -1.42 | 0.02 |
| Stochastic Oscillator | 15.86 | 46.71 |
Anglogold Ashanti PLC is an independent gold mining company. It has a diversified asset portfolio, including production from operations in eight countries (Argentina, Australia, Brazil, Egypt, Ghana, Guinea, the DRC, and Tanzania), supported by greenfield projects in the United States and Colombia. The company's main product is gold, which once mined, is processed into dore (unrefined gold bars) on site and then dispatched to precious metals refineries. Geographically, Anglogold generates maximum revenue from its operations in Africa (comprising operations at Kibali, Iduapriem, Obuasi, Siguiri, Geita, and Sukari mines), followed by Australia (including Sunrise Dam and Tropicana), and the Americas (comprising Cerro Vanguardia, AngloGold Ashanti Mineracao, and Serra Grande operations).
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.